Janus Henderson Group’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
Janus Henderson Group's EPRX Position: Q3 2026 in Review
Janus Henderson Group opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q3 2026: 2,732,432 shares worth $25M. The stake represents 0.01% of the portfolio and ranks #590 among its holdings.
70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- Janus Henderson Group held 2,732,432 shares of Eupraxia Pharmaceuticals worth $25M as of Q3 2026.
- Eupraxia Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
- Eupraxia Pharmaceuticals made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #590 holding.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.